Nazartinib for use in the treatment of CNS metastasis

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

TAN, Daniel Shao-Weng,MOODY, Susan

申请号：

AU2019255410

公开号：

AU2019255410A1

申请日:

2019.04.17

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention provides nazartinib, or a pharmaceutically acceptable salt thereof, preferably the mesylate salt thereof, for use in treating or preventing Central Nervous System (CNS) metastasis, brain metastasis, and/or leptomeningeal metastasis, particularly when the CNS or brain metastasis, or leptomeningeal metastasis is present in a patient with locally advanced or metastatic NSCLC.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/